| Enrollment
(Open) |
|
Description
This is a randomized
outpatient study for
subjects dependent on
prescription opioid
analgesics. The primary objective
is to determine whether the
addition of individual drug
counseling to the
prescription of
buprenorphine/naloxone (BUP/NX)
along with Standard Medical
Management (SMM) improves
outcome both during a) an
initial four week treatment
with tape and b) a 12 week
stabilization treatment for
those who do not respond
successfully to the initial treatment
with taper.
|
|
|
For further information on clinical trials, click
here. |
|
| Available Brochures |
|
|
| Patient Brochure |
.PDF
|
.HTML |
|
You need Adobe Acrobat Reader in order to view the .pdf file.
Acrobat Reader can be downloaded for free from www.adobe.com. |
|
| Principal Investigators: |
Roger Weiss, M.D.
E-Mail : rweiss@mclean.harvard.edu
Phone : (617) 855-2242
Walter Ling, M.D.
E-Mail : lwalter@ix.netcom.com
Phone : (310) 267-5888
|
| NODES & CTPs: |
Northern New England
Node (Lead)
Mclean Hospital - Alcohol and Drug Abuse Treatment Program
Pacific
Node (Lead)
Integrated Substance Abuse Programs
Appalachian Tri-State
Node
Chestnut Ridge Hospital
California-Arizona Node
San Francisco General Hospital
Long Island Node
St. Luke's Roosevelt Hospital Center
New York Node
Bellevue Hospital Center
Ohio Valley Node
East Indiana Treatment Center
Oregon/Hawaii Node
ADAPT, Inc.
Pacific Northwest Node
Providence Behavioral Health Service
Southern Consortium Node
Behavioral Health Services of Pickens County
Texas Node
Homeward Bound, Inc.
|
|
